Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability ...
Research and development expenses for the third quarter of 2025 were $52.4 million versus $37.1 million for the comparable quarter in 2024, reflecting an increase in overall clinical expenses ...
Microsoft will launch .NET 10 at its annual .NET virtual conference, .NET Conf, next week from November 11 to 13, 2025.
Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) andNon-arteritic Anterior Ischemic Optic Neuropathy (NAION) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback